LL/2 Syngeneic Model

Synonyms: LL2, Lewis lung carcinoma 2, Lewis lung cancer cell line

LL/2 is a widely studied cancer cell line commonly used in lung cancer research. Derived from Lewis lung carcinoma in a C57BL/6 mouse, LL/2 cells exhibit aggressive tumorigenic behavior, making them valuable for investigating tumor progression, metastasis, and therapeutic interventions. Their versatility and well-characterized features contribute to advancing our understanding of lung cancer biology and drug discovery.

Model Details

Cancer Type: Lung Cancer
Model Name: LL/2
Mouse Strain: C57BL/6
Treatment Data Available: aPD-1, aCTLA-4, Chemotherapy

LL/2 Growth Curves: Response to aCTLA-4, aPD-1, and Cytoxan

Growth of subcutaneous LL/2 in C57BL/6 mice (n=10). Response to aCTLA-4 dosed Q3D x 4 , aPD-1 dosed Q3D x 4, and Cytoxan dosed QoD x 3 .

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content